Advertisement

Topics

Capital Royalty L.P. Company Profile

02:43 EST 17th December 2018 | BioPortfolio

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalty has the market knowledge and financial know how necessary to help you maximize the value of your royalty interest.

Location

1000 Main, Suite 2500
Houston
Texas
77002
United States of America

Contact

Phone: (713) 209-7350
Fax: (713) 209-7351
Email: jwebster@capitalroyalty.com


News Articles [576 Associated News Articles listed on BioPortfolio]

#Cannabisstocks: Tidal Royalty (CSE: RLTY.U) (OTC: TDRYF) and CannaRoyalty (CSE: CRZ) (OTC: CNNRF) Agree to Terms On Purchase of AltMed Royalty and Equity

Toronto, Ontario - August 27, 2018 (Newsfile Corp.) (Investorideas.com Newswire) Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) ("Tidal Royalty"), a leading provider of royalty financing to licensed U...

Royalty, Zealand to enter deal on diabetes drugs

Royalty Pharma will acquire Zealand Pharma's royalty rights and potential commercial milestones worth $85 million tied to Lyx -More- 

Paul Capital Partners: Growth Capital Providers for the Biotech Industry

In this interview, filmed during the recent BIO conference in San Diego, Fintan Walton speaks with Ken Macleod, partner in the well-known Paul Capital Partners, located in London. He tells how the com...

#Cannabisstocks: Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) Announces Listing on United States OTC Market

Toronto, Ontario - July 16, 2018 (Newsfile Corp.) (Investorideas.com Newswire) Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) ("Tidal Royalty" or the "Company"), a leading provider of royalty financin...

Zealand Pharma sells Soliqua and Lyxumia royalty interests to Royalty Pharma for $205mm

Zealand Pharma AS agreed to sell future royalty streams and $85mm in potential milestone payments related to its diabetes drugs Soliqua 100/33/ Suliqua (insulin glargine/lixisenatide) and Lyxumia/Adly...

#Cannabisstocks; Tidal Royalty Corp. (CSE: RLTY) Commences Trading on Canadian Securities Exchange & Adds Industry Leaders to its Advisory Board

Toronto, Ontario - June 25, 2018 (Newsfile Corp.) (Investorideas.com Newswire) Tidal Royalty Corporation (CSE: RLTY) ("Tidal Royalty" or "the Company"), a leading provider of royalty financing to the ...

Abzena (ABZA) - FY18 results – clouds lifting

Edison Investment Research - Pharmaceutical & healthcare - Abzena: Following a stronger H2 and Abzena’s FY18 results, we have made major changes to our model across both the services business an...

Zealand Abandons Sanofi Diabetes Drug in $205 Million Deal with Royalty Pharma

Copenhagen-based Zealand Pharma is selling future royalty streams and $85 million in potential commercial milestones for two diabetes drugs, Soliqua/Suliqua and Lyxumia/Adlyxin, to New York-based Roya...

PubMed Articles [115 Associated PubMed Articles listed on BioPortfolio]

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Social Capital, Community Capacity, and Health.

The capacity to practice health behavior is different for each individual. Community capacity and social capital deal with understanding the relationship between community members and with the factors...

Is community social capital associated with subjective symptoms of dementia among older people? A cross-sectional study in Japan.

Many studies have reported the preventive effects of community social capital on health outcomes, such as mortality and incidence of diseases. However, evidence on the association between community so...

Social capital interventions in public health: A systematic review.

Despite two decades of research on social capital and health, intervention studies remain scarce. We performed a systematic review on social capital interventions in public health and searched the Pub...

A comparative study of social capital and hospital readmission in older adults.

Numerous factors contribute to hospital readmissions of older adults. The role social capital may play in preventing hospital readmissions is unknown. The aim of this descriptive, cross-sectional stud...

Clinical Trials [56 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

To Develop a Validated Program and Use it to Evaluate Patients Post-operatively

Annually, the Department of Anesthesiology, Siriraj hospital has responsibilities to take care of more than 50,000 patients peri-operatively. According to Maslow's hierarchy of needs; huma...

Companies [1108 Associated Companies listed on BioPortfolio]

Capital Royalty L.P.

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalt...

DRUG ROYALTY CORPORATION INC

A pioneer in the field when launched in 1992, Drug Royalty was the first firm to provide royalty-based financing in the life sciences sector and the first to complete royalty transactions with invento...

DRI Capital Inc.

DRI is a pioneer and global leader in healthcare royalty investing and has completed transactions with large global pharmaceutical companies, biotechnology companies, universities...

Drug Royalty

Drug Royalty is an innovative and profitable Canadian company involved in the international life science industry. Established in 1992, DRC was designed to participate in the growth from the global he...

HealthCare Royalty Partners

HealthCare Royalty Partners (HCRP) is a global healthcare investment firm focused on investing primarily in commercial stage healthcare product assets. HCRP manages over $3 billio...

More Information about "Capital Royalty L.P." on BioPortfolio

We have published hundreds of Capital Royalty L.P. news stories on BioPortfolio along with dozens of Capital Royalty L.P. Clinical Trials and PubMed Articles about Capital Royalty L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Capital Royalty L.P. Companies in our database. You can also find out about relevant Capital Royalty L.P. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record